Related Experiment Video
Updated: May 5, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
Siwanon Jirawatnotai1, Yiduo Hu, Wojciech Michowski
1Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA.
Abstract:
Cyclin D1 is a component of the core cell cycle machinery. Abnormally high levels of cyclin D1 are detected in many human cancer types. To elucidate the molecular functions of cyclin D1 in human cancers, we performed a proteomic screen for cyclin D1 protein partners in several types of human tumours. Analyses of cyclin D1 interactors revealed a network of DNA repair proteins, including RAD51, a recombinase that drives the homologous recombination process. We found that cyclin D1 directly binds RAD51, and that cyclin D1-RAD51 interaction is induced by radiation. Like RAD51, cyclin D1 is recruited to DNA damage sites in a BRCA2-dependent fashion. Reduction of cyclin D1 levels in human cancer cells impaired recruitment of RAD51 to damaged DNA, impeded the homologous recombination-mediated DNA repair, and increased sensitivity of cells to radiation in vitro and in vivo. This effect was seen in cancer cells lacking the retinoblastoma protein, which do not require D-cyclins for proliferation. These findings reveal an unexpected function of a core cell cycle protein in DNA repair and suggest that targeting cyclin D1 may be beneficial also in retinoblastoma-negative cancers which are currently thought to be unaffected by cyclin D1 inhibition.
Insights
Cyclin D1, a cell cycle protein, unexpectedly aids DNA repair by binding RAD51 at damage sites. Inhibiting cyclin D1 may treat retinoblastoma-negative cancers, expanding its therapeutic potential.
Area of Science:
- Molecular Biology
- Cancer Research
- DNA Repair Mechanisms
Background:
- Cyclin D1 is a key cell cycle regulator frequently overexpressed in human cancers.
- Its precise role in cancer beyond cell cycle progression remains incompletely understood.
Purpose of the Study:
- To identify novel molecular functions of cyclin D1 in human cancer.
- To investigate the interaction between cyclin D1 and DNA repair pathways.
Main Methods:
- Proteomic screening to identify cyclin D1 interacting proteins in human tumors.
- Co-immunoprecipitation and immunofluorescence to study protein interactions and localization.
- Assessment of DNA repair capacity and cellular sensitivity to radiation upon cyclin D1 depletion.
Main Results:
- Proteomic analysis revealed that cyclin D1 interacts with DNA repair proteins, notably RAD51.
- Cyclin D1 directly binds RAD51, and this interaction is radiation-induced and BRCA2-dependent.
- Depletion of cyclin D1 impairs RAD51 recruitment to DNA damage sites, hinders homologous recombination repair, and increases radiosensitivity, even in retinoblastoma-negative cancer cells.
Conclusions:
- Cyclin D1 possesses a previously unrecognized function in homologous recombination-mediated DNA repair.
- Targeting cyclin D1 may offer therapeutic benefits for retinoblastoma-negative cancers, a group not typically considered responsive to cyclin D1 inhibition.
Related Concept Videos
Positive Regulator Molecules
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Positive Regulator Molecules
Inhibition of Cdk Activity
DNA Damage Can Stall the Cell Cycle

